Mubadala and Kohlberg Sign Agreement to Acquire Stake in PCI Pharma Services | Financial Buzz

Mubadala and Kohlberg Sign Agreement to Acquire Stake in PCI Pharma Services

PCI Pharma Services and Partners group announced the signing of a definitive agreement to acquire a majority stake in the company by Kohlberg & Company, LLC. Kohlberg is a private equity firm located in Mount Kisco with success in partnering with management companies such as PCI Pharma Services.  Partners group is a global private markets investment manager that has approved the sale of its majority equity stake in PCI Pharma Services, representing its clients with its investment partners Thomas H. Lee Partners and Frazier Healthcare Partners.  Follow the sale to Kohlberg and Mubadala, Partners Group will hold a minority equity stake in the company.  Terms have not been disclosed. 

“PCI teams have embarked on a purposeful journey over recent years to transform the company by executing a successful growth strategy, providing customers with innovative and integrated supply chain solutions with the industry-leading customer experience by differentiating through investment in global capabilities, operational excellence, technology and our biggest asset, our talented people“, said Salim Haffar, PCI’s CEO, “and I am grateful for the support of our board and the director representatives from Partners Group, THL and Frazier.”

Haffar continues, “Kohlberg brings considerable successful experience in the biopharmaceuticals and medical device areas, and I am thrilled to be continuing with them to accelerate the growth of our commercial, clinical trial services, and development manufacturing businesses under this new alliance. Both Kohlberg and Mubadala’s experience and track record in supporting successful management teams will make a great impact on PCI’s continued journey of transformation as we focus on building capabilities to support the future demands of our biopharmaceutical customers in our shared goal of bringing life changing therapies to patients worldwide“.

“We identified PCI through our Outsourced Pharmaceutical Services White Paper, and our larger industry practice in Pharmaceutical and Medical Products & Services, as a best-in-class company led by a premier management team. We are honored to have the opportunity to work with Salim and his team on their next phase of transformational growth and value creation,” commented Chris Anderson, Partner of KohIberg.